The Journal of Primary Prevention

, Volume 35, Issue 2, pp 93–102 | Cite as

Getting the Shots: Methods to Gain Adherence to a Multi-Dose Vaccination Program for Inner City, Drug-Involved Prostitution Communities

  • Giffin W. Daughtridge
  • Timothy W. Ross
  • Paola A. Ceballos
  • Carmen E. Stellar
Original Paper


Street-based sex-work and poly-substance drug use, coupled with low vaccination rates and limited utilization of the mainstream health care system, put the sex worker communities of Bogotá’s city center at extreme risk of infection with the hepatitis B virus (HBV). Vaccination is critical to maintaining low prevalence of the disease and low incidence of new cases, yet the floating and inconsistent nature of Bogotá’s drug-involved female and transsexual prostitution communities make it difficult to complete a 3-dose vaccination program. Between December 2011 and March of 2012, the Fénix Foundation collaborated with the Bogotá Health Department to deliver free HBV vaccines to this vulnerable population. This paper outlines methods used in the vaccination program to generate a 37.7 % adherence rate, significantly higher than that previously reported for HBV vaccination programs also targeting marginalized populations. This program’s practices are based on the Fénix peer leader method, and are offered as a model that can be applied to other health interventions operating in analogous contexts, with similarly high-risk populations.


Hepatitis B Vaccination Prostitution Peer leaders Health intervention adherence Street communities 



The authors gratefully acknowledge the support of the Fulbright US Student Program.


  1. Adams, M., Jasani, B., & Fiander, A. (2009). Prophylactic HPV vaccination for women over 18 years of age. Vaccine, 27(25–26), 3391–3394.PubMedCrossRefGoogle Scholar
  2. Adkins, J. C., & Wagstaff, A. J. (1998). Recombinant hepatitis B vaccine: A review of its immunogenicity and protective efficacy against hepatitis B. BioDrugs, 10(2), 137–158.PubMedCrossRefGoogle Scholar
  3. Amaya, A., Canaval, G. E., & Viafara, E. (2005). Estigmatización de las trabajadoras sexuales: Influencias en la salud. Colombia Médica, 36(3, Supl 2), 65–74.Google Scholar
  4. Bindel, J., & Kelly, L. (2003). A critical examination of responses to prostitution in four countries: Victoria. Australia: Child and Women Abuse Studies Unit, London Metropolitan University.Google Scholar
  5. Brown, B., Carcamo, C., Blas, M. M., Valderrama, M., & Halsey, N. (2010). Peruvian FSWs: Understanding HPV and barriers to vaccination. Vaccine, 28(49), 7743–7747.PubMedCrossRefGoogle Scholar
  6. Camejo, M. I., Mata, G., & Díaz, M. (2003). Prevalence of hepatitis B, hepatitis C and syphilis in female sex workers in Venezuela. Revista de Saúde Pública, 37(3), 339–344.PubMedCrossRefGoogle Scholar
  7. Caprecom. (2013). Regimen Subsidiado. Retrieved from website:
  8. Cassidy, W. M., Watson, B., Loli, V. A., Williams, K., Bird, S., & West, D. J. (2001). A randomized trial of alternative two- and three-dose hepatitis B vaccination regimens in adolescents: Antibody responses, safety, and immunologic memory. Pediatrics, 107(4), 626–631.PubMedCrossRefGoogle Scholar
  9. Dror, D. M., & Jacquier, C. (1999). Micro-insurance: Extending health insurance to the excluded. International Social Security Review, 52(1), 71–97.CrossRefGoogle Scholar
  10. Francis, D. P., Hadler, S. C., Thompson, S. E., Maynard, J. E., Ostrow, D. G., Altman, N., et al. (1982). The prevention of hepatitis B with vaccine: Report of the Centers for Disease Control multi-center efficacy trial among homosexual men. Annals of Internal Medicine, 97(3), 362–366.PubMedCrossRefGoogle Scholar
  11. Future II Study Group. (2007). Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. New England Journal of Medicine, 356(19), 1915–1927.CrossRefGoogle Scholar
  12. Gray, G. E., & Michael, N. L. (2013). Cautious optimism for HIV vaccine science. Current Opinion in HIV & AIDS, 5, 367–368.CrossRefGoogle Scholar
  13. Gust, I. D. (1996). Epidemiology of hepatitis B infection in the Western Pacific and South East Asia. Gut, 38(suppl 2), S18–S23.PubMedCrossRefGoogle Scholar
  14. Hadler, S. C., & Margolis, H. S. (1993). Epidemiology of hepatitis B virus infection. In R. W. Ellis (Ed.), Hepatitis B vaccines in clinical practice (pp. 141–157). New York: Marcel Dekker Inc.Google Scholar
  15. Hérnandez-Bernal, F., Aguilar-Betancourt, A., Aljovin, V., Arias, G., Valenzuela, C., de Alejo, K. P., et al. (2011). Comparison of four recombinant hepatitis B vaccines applied on an accelerated schedule in healthy adults. Human Vaccines & Immunotherapeutics, 7(10), 1026–1036.CrossRefGoogle Scholar
  16. Houghton, M., Law, J. L., & Tyrrell, D. L. (2013). An inactivated hepatitis C virus vaccine on the horizon? Gastroenterology, 145(2), 285–288.PubMedCrossRefGoogle Scholar
  17. Jeal, N., & Salisbury, C. (2004). Self-reported experiences of health services among female street-based prostitutes: A cross-sectional survey. The British Journal of General Practice, 54(504), 515.PubMedCentralPubMedGoogle Scholar
  18. Lavanchy, F. (2004). Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. Journal of Viral Hepatitis, 11, 97–107.PubMedCrossRefGoogle Scholar
  19. Mak, R., Traen, A., Claeyssens, M., Van Renterghem, L., Leroux-Roels, G., & Van Damme, P. (2003). Hepatitis B vaccination for sex workers: Do outreach programmes perform better? Sexually Transmitted Infections, 79, 157–159.PubMedCrossRefGoogle Scholar
  20. Marchou, B., Picot, N., Chavanet, P., Auvergnat, J. C., Armengaud, M., Devilliers, P., et al. (1993). Three-week hepatitis B vaccination provides protective immunity. Vaccine, 11(14), 1383–1385.PubMedCrossRefGoogle Scholar
  21. Mast, E. E., Weinbaum, C. M., Fiores, A. E., Alter, M. J., Bell, B. O., Finelli, L., et al. (2006). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. Atlanta: Centers for Disease Control and Prevention (CDC).Google Scholar
  22. Mayor Mora, A., Arias, A., Menjura, F. H., & Jaramillo Ángel, L. F. (2010). Cruzada interminable por la niñez Colombiana. Historia del programa ampliado de inmunizaciones—PAI—en Colombia 1979–2009. Bogotá: Ministerio de la Protección Social, Organización Panamericana de la Salud.Google Scholar
  23. Mejia, A., Bautista, C. T., Leal, L., Ayala, C., Prieto, F., de la Hoz, F., et al. (2009). Syphilis infection among female sex workers in Colombia. Journal of Immigrant and Minority Health, 11(2), 92–98.PubMedCrossRefGoogle Scholar
  24. Mejia, A.M., Montano, S.M., Vallejo, F., Prieto, F., Acosta, J., De La Hoz, F., Velandia, M.P., Sanchez, J.L., & Olson, J.G. (2002). HIV-1, syphilis and hepatitis B virus prevalence and risk factors among commercial sex workers, Bogotá, Colombia. Poster Exhibit: The XV International AIDS Conference: Abstract no. WePeC6251.Google Scholar
  25. O’Rourke, K. M., Redlinger, T. E., & Steege, A. M. (2001). Improving hepatitis B immunization among high-risk adolescents: A low-cost intervention on the Mexico-United States border. Revista Panamericana de Salud Pública, 9, 4.Google Scholar
  26. Pinzón-Rondón, A. M., Ross, T. W., Botero, J. C., & Baquero-Umaña, M. M. (2009). Prevalencia y factores asociados a enfermedades de transmisión sexual en menores explotados sexualmente en Bogotá, Colombia. Revista de Salud Pública, 11(3), 468–479.PubMedCrossRefGoogle Scholar
  27. Ritterbusch, A. (2011). A youth vision of the city: The socio-spatial lives and exclusion of street girls in Bogotá, Colombia. ProQuest ETD Collection for FIU. Paper AAI3484191.
  28. Rogers, N., & Lubman, D. I. (2005). An accelerated hepatitis B vaccination schedule for young drug users. Australian and New Zealand Journal of Public Health, 29(4), 305–307.PubMedCrossRefGoogle Scholar
  29. Ross, T. (1992). Using and dealing on Calle 19: A high risk street community in central Bogotá. International Journal of Drug Policy, 13, 45–56.CrossRefGoogle Scholar
  30. Szumeness, W., Stevens, C. E., Harley, E. J., Zang, E. A., Oleszko, W. R., William, D. C., et al. (1980). Hepatitis B vaccine: Demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. New England Journal of Medicine, 303(15), 833–841.CrossRefGoogle Scholar
  31. Valente, T. W., & Pumpuang, P. (2007). Identifying opinion leaders to promote behavior change. Health Education & Behavior, 34, 881.CrossRefGoogle Scholar
  32. WHO. (2009). Hepatitis B vaccines: WHO position paper-recommendations. Vaccine, 28(3), 589–590.Google Scholar
  33. WHO. (2012a). Hepatitis B fact sheet no. 204. Retrieved from website:
  34. WHO. (2012b) Hepatitis C fact sheet no. 164. Retrieved from website:
  35. WHO. (2012c) HIV/AIDS fact sheet no. 360. Retrieved from website:
  36. Wiebel, W. (1993). The indigenous leader outreach model: Intervention manual. Rockville, MD: US Department of Health and Human Services, National Institute on Drug Abuse.Google Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Giffin W. Daughtridge
    • 1
    • 5
  • Timothy W. Ross
    • 2
  • Paola A. Ceballos
    • 3
  • Carmen E. Stellar
    • 4
  1. 1.Perelman School of Medicine at the University of PennsylvaniaPhiladelphiaUSA
  2. 2.Fundación Social FénixBogotáColombia
  3. 3.Universidad de La SalleBogotáColombia
  4. 4.Weill Cornell Medical CollegeNew YorkUSA
  5. 5.PhiladelphiaUSA

Personalised recommendations